- Home
- ARVN vs YSG Comparison
ARVN vs YSG Comparison
Compare ARVN & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | YSG |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 889.0M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARVN | YSG |
|---|---|---|
| Price | $13.48 | $3.94 |
| Analyst Decision | Buy | |
| Analyst Count | 23 | 0 |
| Target Price | ★ $18.14 | N/A |
| AVG Volume (30 Days) | ★ 753.9K | 113.7K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $312,300,000.00 | ★ $571,300,568.00 |
| Revenue This Year | $10.55 | $28.96 |
| Revenue Next Year | N/A | $16.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.86 | 22.59 |
| 52 Week Low | $5.90 | $3.12 |
| 52 Week High | $20.38 | $11.57 |
Technical Indicators
Market Signals| Indicator | ARVN | YSG |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 39.77 |
| Support Level | $12.88 | $3.83 |
| Resistance Level | $14.14 | $4.59 |
| Average True Range (ATR) | 0.70 | 0.23 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 67.89 | 15.19 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.